Intravenous iron for the treatment of predialysis anemia
- 1 March 1999
- journal article
- review article
- Published by Elsevier BV in Kidney International
- Vol. 55, S79-S85
- https://doi.org/10.1046/j.1523-1755.1999.055suppl.69079.x
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Anemia during the Predialysis Period: A Key to Cardiac Damage in Renal FailureNephron, 1998
- Correction of uremic iron deficiency anemia in hemodialyzed patients: a prospective study.Nephron, 1998
- Iron absorption in erythropoietin-treated haemodialysis patients: effects of iron availability, inflammation and aluminium.Nephrology Dialysis Transplantation, 1998
- Cardiovascular effects of recombinant human erythropoietin in predialysis patientsAmerican Journal of Kidney Diseases, 1997
- The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal diseaseAmerican Journal of Kidney Diseases, 1996
- Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for interventionAmerican Journal of Kidney Diseases, 1996
- Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysisAmerican Journal of Kidney Diseases, 1996
- Cardiac function and hematocrit levelAmerican Journal of Kidney Diseases, 1995
- Report on Management of Renal Failure in Europe, XXIV, 1993Nephrology Dialysis Transplantation, 1995
- Iron Metabolism in Patients with Chronic Renal FailureClinical Science, 1970